Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis

Journal of Rheumatology

Volumn 38, Issue 12, 2011, Pages 2608-2615

  Mattey, Derek L ^a   Dawson, Sarah R ^b   Healey, Emma L ^a   Packham, Jonathan C ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Ankylosing spondylitis; Disease activity; Outcomes; Quality of life; Tobacco

Indexed keywords

ADULT; AGE DISTRIBUTION; ANKYLOSING SPONDYLITIS; ANKYLOSING SPONDYLITIS QUALITY OF LIFE QUESTIONNAIRE; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EVALUATION OF ANKYLOSING SPONDYLITIS QUALITY OF LIFE QUESTIONNAIRE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SMOKING; SOCIAL ISOLATION; TOWNSEND INDEX SCORE; UNITED KINGDOM;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SMOKING; SPONDYLITIS, ANKYLOSING;

EID: 82755162887     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110641     Document Type: Article

References (38)

1. McVeigh CM, Cairns AP. Diagnosis and management of ankylosing spondylitis. BMJ 2006;333:581-5. (Pubitemid 44433633)
2. Khan MA. Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt MH, editors. Rheumatology. 3rd ed. London: Mosby; 2003:1161-81.
3. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997;36:766-71.
4. Guillemin F, Briancon S, Pourel J, Gaucher A. Long-term disability and prolonged sick leave as outcome measures in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 1990;33:1001-6. (Pubitemid 20226354)
5. Ward MM. Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 2002;29:1420-5. (Pubitemid 34755608)
6. Kaan U, Ferda O. Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int 2005;25:357-60. (Pubitemid 40931908)
7. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 1996;25:138-42. (Pubitemid 26180272)
8. Doran MF, Brophy S, Mackay K, Taylor G, Calin A. Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 2003;30:316-20. (Pubitemid 36152597)
9. Ward MM, Weisman MH, Davis JC, Reveille JD. Risk factors for functional limitations in patients with longstanding ankylosing spondylitis. Arthritis Care Res 2005;53:710-7. (Pubitemid 41463836)
10. Reed MD, Dharmage S, Boers A, Martin BJ, Buchanan RR, Schachna L. Ankylosing spondylitis: an Australian experience. Intern Med J 2008;38:321-7. (Pubitemid 351519481)
11. Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis JC Jr, Reveille JD, et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Care Res 2009;61:859-66.
12. Bodur H, Ataman S, Rezvani A, Bugdayci DS, Cevik R, Birtane M, et al. Quality of life and related variables in patients with ankylosing spondylitis. Qual Life Res 2011;20:543-9.
13. Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwarz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997;56:463-9. (Pubitemid 27396032)
14. Wolfe F. The effect of smoking on clinical, laboratory and radiographic status in rheumatoid arthritis. J Rheumatol 2000;27:630-7. (Pubitemid 30151338)
15. Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarsson H. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology 2000;39:1202-5.
16. Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, et al. Smoking and disease severity in rheumatoid arthritis. Association with polymorphism at the gluatathione S- transferase (GST) M1 locus. Arthritis Rheum 2002;46:640-6. (Pubitemid 34214246)
17. Mattey DL, Dawes PT, Fisher J, Brownfield A, Thomson W, Hajeer AH, et al. Nodular disease in rheumatoid arthritis: Association with cigarette smoking and HLA-DRB1/TNF gene interaction. J Rheumatol 2002;29:2313-8. (Pubitemid 35266021)
18. Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005;23:861-6. (Pubitemid 43040515)
19. Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M, et al. The effect of tobacco smoking and rheumatoid factor positivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 2006:45:734-40. (Pubitemid 43985343)
20. Dincer U, Cakar E, Kiralp MZ, Bozkanat E, Kilac H, Dursun H. The pulmonary involvement in rheumatic diseases: Pulmonary effects of ankylosing spondylitis and its impact on functionality and quality of life. Tohoku J Exp Med 2007;212:423-30. (Pubitemid 351565840)
21. Haywood KL, Garratt AM, Jordan KP, Healey EL, Packham JC. Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL): Reliability and validity of a new patient-reported outcome measure. J Rheumatol 2010;37:2100-9.
22. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 1984;27:361-8.
23. Townsend P, Phillimore P, Beattie A. Health and deprivation: Inequality and the North. London: Croom Helm; 1998.
24. Mattey DL, Brownfield A, Dawes PT. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. J Rheumatol 2009;36:1180-7.
25. Mattey DL, Dawes PT, Hassell AB, Brownfield A, Packham JC. Effect of psychological distress on continuation of anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. J Rheumatol 2010;37:2021-4.
26. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: A quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6. (Pubitemid 36005790)
27. National Institute for Health and Clinical Excellence. Adalimumab, entanercept and infliximab for ankylosing spondylitis. NICE technology appraisal guidance 143. [Internet. Accessed Aug 30, 2011.] Available from: http://www.nice.org.uk/nicemedia/pdf/TA143Guidance.pdf
28. Healey EL, Haywood KL, Jordan KP, Garratt AM, Packham JC. Disease severity in ankylosing spondylitis: Variation by region and local area deprivation. J Rheumatol 2010;37:633-8.
29. Office for National Statistics. General Lifestyle Survey 2008: Smoking and drinking among adults 2008. London: Office for National Statistics. [Internet. Accessed Sept 20, 2011.] Available from: http://www.ons.gov.uk/ons/ publications/re-reference-tables.html?edition=tcm%3A77-49408.
30. Hyrich KL, Watson KD, Silman AJ, Symmons DPM, and The BSR Biologics Register. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Rheumatology 2006;45:1558-65. (Pubitemid 44817065)
31. Abhishek A, Butt S, Gadsby K, Zhang W, Deighton CM. Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers. J Clin Rheumatol 2010;16:15-8.
32. Saevarsdottir S, Wedren S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum 2011;63:26-6.
33. Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Peterssson IF, et al. Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 2011;70:469-75.
34. Westhoff G, Rau R, Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology 2008;47:849-54. (Pubitemid 351796371)
35. Amin S, Niu J, Guermazi A, Grigoryan M, Hunter DL, Clancy M, et al. Cigarette smoking and the risk for cartilage loss and knee pain in men with knee osteoarthritis. Ann Rheum Dis 2007;66:18-22. (Pubitemid 46044855)
36. Brage S, Bjerkedal T. Musculoskeletal pain and smoking in Norway. J Epidemiol Community Health 1996;26:49-54.
37. Eriksen WB, Brage S, Bruusgard D. Does smoking aggravate musculoskeletal pain? Scand J Rheumatol 1997;26:49-54. (Pubitemid 27105161)
38. Palmer KT, Syddall H, Cooper C, Coggon D. Smoking and musculoskeletal disorders: findings from a British national survey. Ann Rheum Dis 2003:62:33-6. (Pubitemid 36005792)